May 232017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, WA – Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced it has appointed Jay Flatley to its Board of Directors.… => Read more

Juno Therapeutics appoints Jay Flatley to the Board of Directors

From:: Juno Therapeutics appoints Jay Flatley to the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: